Development of a checklist of short-term and long-term psychological symptoms associated with ketamine use.
Ni Fan, Ke Xu, Yuping Ning, Daping Wang, Xiaoyin Ke, Yi Ding, Bin Sun, Chao Zhou, Xuefeng Deng, Robert Rosenheck, Hongbo He
Shanghai archives of psychiatry June 1, 2015 DOI: 10.11919/j.issn.1002-0829.214158 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Scale development and validation study using exploratory and confirmatory factor analysis Peer reviewed |
|---|---|
| Sample size | 187 |
| Population | Inpatients with ketamine dependence recruited from two large hospitals in Guangzhou, China |
| Topics | Ketamine Esketamine |
| Keywords | China Factor analysis Substance-related disorders Questionnaire Signs and symptoms |
| Key points | The most-reported acute effects of ketamine use were 'floating or circling' (94%), 'euphoric when listening to rousing music' (86%), and 'feeling excited, talkative, and full of energy' (67%), while the most-reported long-term symptoms were 'memory impairment' (93%), 'personality changes' (86%), and 'slowed reactions' (81%). A final 22-item scale was best described by a four-factor model (social withdrawal, sleep disturbance, acute psychotic-like symptoms, and combined acute euphoria and longer-term decreased libido) accounting for 50% of total variance, with fair model fit (GFI=83.3%; RMSEA=0.072). The authors conclude this provides a fair description of short- and long-term psychological symptoms of ketamine use, pending validation in larger samples. |
Abstract
Background: Ketamine is an increasingly popular drug of abuse in China but there is currently no method for classifying the psychological effects of ketamine in individuals with ketamine dependence.
Aim: Develop a scale that characterizes the acute and long-term psychological effects of ketamine use among persons with ketamine dependence.
Methods: We developed a preliminary symptom checklist with 35 dichotomous ('yes' or 'no') items about subjective feelings immediately after ketamine use and about perceived long-term effects of ketamine use that was administered to 187 inpatients with ketamine dependence recruited from two large hospitals in Guangzhou, China. Exploratory factor analysis (EFA) was conducted on a randomly selected half of thesample to reduce the items and to identify underlying constructs. Confirmatory factor analysis (CFA) was conducted on the second half of the sample to assess the robustness of the identified factor structure.
Results: Among the 35 symptoms, the most-reported acute effects were 'floating or circling' (94%), 'euphoric when listening to rousing music' (86%), and 'feeling excited, talkative, and full of energy' (67%). The mostreported long-term symptoms were 'memory impairment' (93%), 'personality changes' (86%), and 'slowed reactions' (81%). EFA resulted in a final 22-item scale best modelled by a four-factor model: two factors representing chronic symptoms (social withdrawal and sleep disturbances), one about acute psychoticlike symptoms, and one that combined acute drug-related euphoria and longer-term decreased libido. CFA showed that these 4 factors accounted for 50% of the total variance of the final 22-item scale and that the model fit was fair (Goodness of Fit Index, GIF=83.3%; Root Mean Square Error of Approximation, RMSEA=0.072).
Conclusion: A four-factor model including social withdrawal, sleep disturbance, psychotic-like symptoms, and euphoria at the time of drug use provides a fair description of the short-term and long-term psychological symptoms associated with ketamine use. Future work on the 22-item version of the scale with larger samples is needed to confirm the validity of this 4-factor structure, to assess the scale's test-retest reliability, and to determine whether or not it can be useful in the differential diagnosis and monitoring of treatment of individuals with ketamine dependence.
Citations in the library
Cited by 3
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism American Journal of Psychiatry August 29, 2018
- Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models Zebrafish March 22, 2016
- The Relationship Between Ketamine and Memory Impairment: A Systematic Review Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi May 21, 2024
Cites 5
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia. Cognitive Neuropsychiatry February 6, 2011
- Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biological Psychiatry January 15, 2010
- Journey through the K-hole: phenomenological aspects of ketamine use. Drug and Alcohol Dependence March 19, 2008